For patients who respond to these medications, we would anticipate that [they] would respond with weight loss within the first month, she says
Methods: In this double-blind trial, we enrolled 1961 adults with a body-mass index (the weight in kilograms divided by the square of the height in meters) of 30 or greater (27 in persons with 1 weight-related coexisting condition), who did not have diabetes, and randomly assigned them, in a 2:1 ratio, to 68 weeks of treatment with once-weekly subcutaneous semaglutide (at a dose of 2.4 mg) or placebo, plus lifestyle intervention
While some individuals may experience weight loss every week while taking semaglutide, weight loss progress can vary from person to person
Semaglutide is part of a drug class known as GLP-1 receptor agonists
Theyre often personalized for patients, so if someone is allergic to an ingredient in a drug, for example, a pharmacist can tweak the formula without getting hit with IP claims from the drugmaker